Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Yoon-Ming Chin"'
Autor:
Xiao-Yu Zuo, Qi-Sheng Feng, Jian Sun, Pan-Pan Wei, Yoon-Ming Chin, Yun-Miao Guo, Yun-Fei Xia, Bo Li, Xiao-Jun Xia, Wei-Hua Jia, Jian-Jun Liu, Alan Soo-Beng Khoo, Taisei Mushiroda, Ching-Ching Ng, Wen-Hui Su, Yi-Xin Zeng, Jin-Xin Bei
Publikováno v:
Biology of Sex Differences, Vol 10, Iss 1, Pp 1-11 (2019)
Abstract Background The male predominance in the incidence of nasopharyngeal carcinoma (NPC) suggests the contribution of the X chromosome to the susceptibility of NPC. However, no X-linked susceptibility loci have been examined by genome-wide associ
Externí odkaz:
https://doaj.org/article/38e8451dc36b44588032740922b7d6f0
Autor:
Hiu Ting Chan, Satoshi Nagayama, Masumi Otaki, Yoon Ming Chin, Yosuke Fukunaga, Masashi Ueno, Yusuke Nakamura, Siew-Kee Low
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
IntroductionCirculating tumor DNA (ctDNA) has been increasingly recognized as a promising minimally-invasive biomarker that could identify patients with minimal residual disease and a high risk of recurrence after definitive treatment. In this study,
Externí odkaz:
https://doaj.org/article/147e9c2fdf894d1b8b75861d5a3c8aa5
Autor:
Hiu Ting Chan, Satoshi Nagayama, Yoon Ming Chin, Masumi Otaki, Rie Hayashi, Kazuma Kiyotani, Yosuke Fukunaga, Masashi Ueno, Yusuke Nakamura, Siew‐Kee Low
Publikováno v:
Molecular Oncology, Vol 14, Iss 8, Pp 1719-1730 (2020)
As the use of next‐generation sequencing (NGS) for plasma cell‐free DNA (cfDNA) continues to expand in clinical settings, accurate identification of circulating tumor DNA mutations is important to validate its use in the clinical management for c
Externí odkaz:
https://doaj.org/article/c7ba8e1582eb4f97ae1453d272fe05a8
Publikováno v:
Oncology and Therapy, Vol 7, Iss 1, Pp 1-32 (2019)
Abstract Cancer pharmacogenomics is the science concerned with understanding genetic alterations and its effects on the pharmacokinetics and pharmacodynamics of anti-cancer drugs, with the aim to provide cancer patients with the precise medication th
Externí odkaz:
https://doaj.org/article/851cf856e6fe4ae2a13577357e2fe242
Autor:
Siew-Kee, Low, Ryo, Ariyasu, Ken, Uchibori, Rie, Hayashi, Hiu Ting, Chan, Yoon Ming, Chin, Takahiro, Akita, Yuhei, Harutani, Ayu, Kiritani, Ryosuke, Tsugitomi, Ryo, Manabe, Shinsuke, Ogusu, Yoshiaki, Amino, Satoru, Kitazono, Noriko, Yanagitani, Yusuke, Nakamura, Makoto, Nishio
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Genomic profiling of tumors from cancer patients facilitates molecular-guided therapy. The turnaround time is one of important issues to deliver results timely for clinical decisions. The Ion Torrent™ Genexus™ Integrated Sequencer aut
Autor:
Allan Hildesheim, Yi-Xin Zeng, Jian-Jun Liu, Gang-Qiao Zhou, Hongxin Zhang, Yun-Fei Xia, Ka-Po Tse, Soo-Hwang Teo, Kin-Choo Pua, Hao-Yuan Mo, Wen-Sheng Liu, Alan Soo-Beng Khoo, Wei-Hua Jia, Yun-Miao Guo, Qi-Shen Feng, Fu-Tuo Feng, Qian Cui, Ming-Yuan Chen, Li-Zhen Chen, Yu-Sun Chang, Chien-Jen Chen, James D. McKay, Wan-Lun Hsu, Pei-Jen Lou, Yoon-Ming Chin, Kai Yu, Ching-Ching Ng, Wen-Hui Su, Jin-Xin Bei
Supplemental Table 1S. Sequenome Primer Design for 43 SNPs included in Our Replications Studies. Supplemental Table 2S. Results from NPC GWAS Meta-Analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37f92857be4594d41c9818f0ae9a5c0b
https://doi.org/10.1158/1055-9965.22437970
https://doi.org/10.1158/1055-9965.22437970
Autor:
Allan Hildesheim, Yi-Xin Zeng, Jian-Jun Liu, Gang-Qiao Zhou, Hongxin Zhang, Yun-Fei Xia, Ka-Po Tse, Soo-Hwang Teo, Kin-Choo Pua, Hao-Yuan Mo, Wen-Sheng Liu, Alan Soo-Beng Khoo, Wei-Hua Jia, Yun-Miao Guo, Qi-Shen Feng, Fu-Tuo Feng, Qian Cui, Ming-Yuan Chen, Li-Zhen Chen, Yu-Sun Chang, Chien-Jen Chen, James D. McKay, Wan-Lun Hsu, Pei-Jen Lou, Yoon-Ming Chin, Kai Yu, Ching-Ching Ng, Wen-Hui Su, Jin-Xin Bei
Supplemental Figure 1S. Individual Study Results from GWAS Meta-Analysis and Replication Studies for Selected SNPs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae5e683123111b2ee46fe4febca3897d
https://doi.org/10.1158/1055-9965.22437973.v1
https://doi.org/10.1158/1055-9965.22437973.v1
Autor:
Allan Hildesheim, Yi-Xin Zeng, Jian-Jun Liu, Gang-Qiao Zhou, Hongxin Zhang, Yun-Fei Xia, Ka-Po Tse, Soo-Hwang Teo, Kin-Choo Pua, Hao-Yuan Mo, Wen-Sheng Liu, Alan Soo-Beng Khoo, Wei-Hua Jia, Yun-Miao Guo, Qi-Shen Feng, Fu-Tuo Feng, Qian Cui, Ming-Yuan Chen, Li-Zhen Chen, Yu-Sun Chang, Chien-Jen Chen, James D. McKay, Wan-Lun Hsu, Pei-Jen Lou, Yoon-Ming Chin, Kai Yu, Ching-Ching Ng, Wen-Hui Su, Jin-Xin Bei
Background: Genetic loci within the major histocompatibility complex (MHC) have been associated with nasopharyngeal carcinoma (NPC), an Epstein-Barr virus (EBV)-associated cancer, in several GWAS. Results outside this region have varied.Methods: We c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bc7b076eeeb3eff007050915cf52da4
https://doi.org/10.1158/1055-9965.c.6516145.v1
https://doi.org/10.1158/1055-9965.c.6516145.v1
Publikováno v:
Cancers. 14(13)
Genomic profiling using tumor biopsies remains the standard approach for the selection of approved molecular targeted therapies. However, this is often limited by its invasiveness, feasibility, and poor sample quality. Liquid biopsies provide a less
Autor:
Yoon Ming Chin, Tomoko Shibayama, Hiu Ting Chan, Masumi Otaki, Fumikata Hara, Takayuki Kobayashi, Kokoro Kobayashi, Mari Hosonaga, Ippei Fukada, Lina Inagaki, Makiko Ono, Yoshinori Ito, Shunji Takahashi, Shinji Ohno, Takayuki Ueno, Yusuke Nakamura, Siew‐Kee Low
Publikováno v:
Cancer science. 113(5)
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) significantly improve progression-free survival and have become the standard therapy for estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer patients.